Jacobson Pharma (HKSE:02633) 3-Year EBITDA Growth Rate : 3.50% (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Jacobson Pharma 3-Year EBITDA Growth Rate?

Jacobson Pharma's EBITDA per Share for the six months ended in Sep. 2024 was HK$0.10.

During the past 12 months, Jacobson Pharma's average EBITDA Per Share Growth Rate was 12.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 3.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 0.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Jacobson Pharma was 27.10% per year. The lowest was -2.60% per year. And the median was 5.30% per year.

Competitive Comparison of Jacobson Pharma's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Jacobson Pharma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jacobson Pharma's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jacobson Pharma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Jacobson Pharma's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Jacobson Pharma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Jacobson Pharma (HKSE:02633) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Jacobson Pharma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Jacobson Pharma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Jacobson Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jacobson Pharma Corp Ltd (HKSE:02633) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

388 Kwun Tong Road, Unit 2313-18, 23rd Floor, Tower 1, Millennium City 1, Kwun Tong, Kowloon, Hong Kong, HKG

Website

http://www.jacobsonpharma.com

Jacobson Pharma Corp Ltd is an investment holding company. It is principally engaged in the development, production, marketing, and sale of generic drugs. The company's operating segment includes Generic drugs; Branded healthcare, Wholesale, and retail The generic drugs segment develops, manufactures, and distributes a host of off-patent medicines for various therapeutic use. It generates maximum revenue from the Generic drugs segment. Geographically, it derives a majority of its revenue from Hong Kong and also has a presence in Mainland China, Macau, Singapore, and Other Countries.

Executives

Queenshill Development Limited
Sum Kwong Yip, Derek	2305 Beneficiary of a trust
Lau Wing Hung
Kingshill Development Group Inc
Kingshill Development Limited
Ubs Trustees (b.v.i.) Limited
Longjin Investments Limited
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si

Jacobson Pharma Headlines

No Headlines